Please check the individual session for location or broadcast availability.
Tannaz Armaghany, MD
Target Audience and Needs
Medical oncologists, hematologists, gastroenterologists, pulmonologists, internists, surgeons, geneticists, palliative care specialists, basic and translational research scientists, residents, fellows, and medical students need to receive regular updates on advances in the diagnosis and management of hematologic disorders and oncologic/hematologic malignancies and related conditions. The series aims to expand the knowledge base of learners in these topic areas, improve their clinical competencies and research skills, enhance patient care, and improve outcomes.
Educational methods will include lectures.
At the conclusion of the sessions, the participants should be able to:
- Describe the pathophysiology and epidemiology of hematologic disorders and oncologic/hematologic malignancies and related conditions..
- Recognize the challenges in diagnosing and managing specific hematologic disorders and oncologic/hematologic malignancies and their disease-related complications.
- Identify the optimal standard of care of each these conditions.
- Glean evidence-based findings from clinical trials and implement them in clinical practice to improve patient care and outcomes.
Participants may be asked to complete a session evaluation.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.